[Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
D000596:Amino Acids / Q000627:therapeutic use; D000641:Ammonia / Q000378:metabolism; D001971:Bromocriptine / Q000627:therapeutic use; D004569:Electroencephalography; D005227:Fatty Acids / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D007792:Lactulose / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D009355:Neomycin / Q000627:therapeutic use; D009420:Nervous System / Q000503:physiopathology; D009460:Neurologic Examination; D018377:Neurotransmitter Agents / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000378:metabolism; D009435:Synaptic Transmission
D000596:Amino Acids; D005227:Fatty Acids; D018377:Neurotransmitter Agents; D013438:Sulfhydryl Compounds; D001971:Bromocriptine; D007792:Lactulose; D007980:Levodopa; D000641:Ammonia; D009355:Neomycin
La terapia dell'encefalopatia epatica. Esperienza personale e revisione della letteratura.